These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 18679176)
1. Pharmacoeconomics in the era of individualized medicine. Waldman SA; Terzic A Clin Pharmacol Ther; 2008 Aug; 84(2):179-82. PubMed ID: 18679176 [No Abstract] [Full Text] [Related]
2. When will the U.S. flinch at cancer drug prices? Vanchieri C J Natl Cancer Inst; 2005 May; 97(9):624-6. PubMed ID: 15870428 [No Abstract] [Full Text] [Related]
3. [Pharmacoeconomics and cost of cancer drugs]. Camps Herrero C; Caballero Díaz C; Blasco Cordellat A Farm Hosp; 2010 Mar; 34 Suppl 1():12-5. PubMed ID: 20920852 [TBL] [Abstract][Full Text] [Related]
4. The economics of drug discovery and the ultimate valuation of pharmacotherapies in the marketplace. Sollano JA; Kirsch JM; Bala MV; Chambers MG; Harpole LH Clin Pharmacol Ther; 2008 Aug; 84(2):263-6. PubMed ID: 18547999 [TBL] [Abstract][Full Text] [Related]
5. No rational theory for drug pricing. Cox MC; Figg WD; Thurman PW J Clin Oncol; 2004 Mar; 22(5):962-3. PubMed ID: 14990657 [No Abstract] [Full Text] [Related]
6. [Pharmacoeconomics. Potent drugs, diseases are costly]. Flaten O Tidsskr Nor Laegeforen; 1994 Apr; 114(11):1345-6. PubMed ID: 8079219 [No Abstract] [Full Text] [Related]
7. The power of pharmacoeconomics. Healthc Exec; 2000; 15(1):44-5. PubMed ID: 11067028 [No Abstract] [Full Text] [Related]
8. Considerations in the pharmacoeconomics of glaucoma. Hirsch JD Manag Care; 2002 Nov; 11(11 Suppl):32-7. PubMed ID: 15357537 [TBL] [Abstract][Full Text] [Related]
9. Using pharmacoeconomics to value pharmacotherapy. Hay JW Clin Pharmacol Ther; 2008 Aug; 84(2):197-200. PubMed ID: 18679182 [TBL] [Abstract][Full Text] [Related]
10. Pharmacoeconomics: determining the value of drug therapy. Peterson C Healthplan; 1998; 39(3):44-50. PubMed ID: 10181751 [No Abstract] [Full Text] [Related]
12. Observational studies and "real world" anesthesia pharmacoeconomics. Miller DR; Tierney M Can J Anaesth; 2002 Apr; 49(4):329-34. PubMed ID: 11927469 [No Abstract] [Full Text] [Related]
13. The pharmacoeconomics of spiralling cancer drug costs - is there a viable solution? Alifrangis C; Krell J; Stebbing J Eur J Cancer; 2011 Jun; 47(9):1285-6. PubMed ID: 21550231 [No Abstract] [Full Text] [Related]
14. Keynote comment: reimbursement for molecularly targeted anticancer agents. Tirelli U; de Castro G; Awada A Lancet Oncol; 2006 Jan; 7(1):2-3. PubMed ID: 16389172 [No Abstract] [Full Text] [Related]
15. [Pharmacoeconomics in contemporary medicine]. Czech M Pol Merkur Lekarski; 2004 May; 16 Suppl 1():16-9. PubMed ID: 15524007 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacoeconomics. A new concept of an old practice]. Palma-Aguirre JA Gac Med Mex; 1998; 134(5):621-4. PubMed ID: 9842147 [No Abstract] [Full Text] [Related]